133 related articles for article (PubMed ID: 7158508)
21. Modulation of antitumor immunity--immunobiologic approaches.
North RJ; Dye ES; Mills CD; Chandler JP
Springer Semin Immunopathol; 1982; 5(2):193-220. PubMed ID: 6293113
[No Abstract] [Full Text] [Related]
22. Enhancement of thermal response of normal and malignant tissues by Corynebacterium parvum.
Urano M; Yamashita T; Suit HD; Gerweck LE
Cancer Res; 1984 Jun; 44(6):2341-7. PubMed ID: 6722772
[TBL] [Abstract][Full Text] [Related]
23. Enhanced thermal response of a rat sarcoma by Corynebacterium parvum.
Shah SA
Cancer Lett; 1985 Mar; 26(2):235-40. PubMed ID: 3978610
[TBL] [Abstract][Full Text] [Related]
24. C. parvum treatment of transplanted rat tumours of spontaneous origin.
Willmott N; Pimm MV; Baldwin RW
Int J Cancer; 1979 Sep; 24(3):323-8. PubMed ID: 385514
[TBL] [Abstract][Full Text] [Related]
25. Association of host immunoglobulins with solid tumours in vivo.
James K; Bessos YH; Merriman J
Br J Cancer; 1979 Nov; 40(5):689-700. PubMed ID: 315785
[TBL] [Abstract][Full Text] [Related]
26. Effect of anti-thymocyte serum, anti-macrophage serum, and latex particles on the therapeutic efficacy of BCG or Corynebacterium liquefaciens (Propionibacterium acnes C7) in syngeneic mice.
Tanaka T; Nakagawa H; Kato A; Yoshimura M; Fujita H; Kimura K
Gan; 1977 Feb; 68(1):45-52. PubMed ID: 324858
[TBL] [Abstract][Full Text] [Related]
27. The activation state of macrophage subpopulations from a murine fibrosarcoma.
Moore K; McBride WH
Int J Cancer; 1980 Nov; 26(5):609-15. PubMed ID: 6263810
[TBL] [Abstract][Full Text] [Related]
28. Effect of C. parvum and active specific immunotherapy on intracerebral transplants of a murine fibrosarcoma.
Woodruff MF; Hitchcock E; Whitehead VL
Br J Cancer; 1977 May; 35(5):687-92. PubMed ID: 861152
[No Abstract] [Full Text] [Related]
29. Efficacy of Corynebacterium parvum treatment of mice with sarcoma growing in normal or irradiated tissue.
Suit HD; Sedlacek R; Echteler S
Cancer Res; 1977 Nov; 37(11):4233-4. PubMed ID: 908052
[No Abstract] [Full Text] [Related]
30. Immunoprophylaxis and immunotherapy for a murine fibrosarcoma with C. granulosum and C. parvum.
Milas L; Gutterman JU; Basic I; Hunter N; Mavligit GM; Hersh EM; Withers HR
Int J Cancer; 1974 Oct; 14(4):493-503. PubMed ID: 4459276
[No Abstract] [Full Text] [Related]
31. In vitro antitumor effect of lymphoid cells from Corynebacterium parvum-treated mice: effect of route of C. parvum administration.
Ghaffar A; Cullen RT
J Natl Cancer Inst; 1977 Mar; 58(3):717-20. PubMed ID: 300113
[TBL] [Abstract][Full Text] [Related]
32. Radiation response of C3H fibrosarcoma enhanced in mice stimulated by Corynebacterium parvum.
Suit HD; Sedlacek R; Wagner M; Orsi L
Nature; 1975 Jun; 255(5508):493-4. PubMed ID: 1138200
[No Abstract] [Full Text] [Related]
33. Macrophage mediated tumor cell cytotoxicity.
Kaplan AM; Morahan PS
Ann N Y Acad Sci; 1976; 276():134-45. PubMed ID: 1071961
[TBL] [Abstract][Full Text] [Related]
34. Possible mechanisms in the anti-tumour activity of C. parvum.
Cullen RT
Dev Biol Stand; 1977 Apr 13-15; 38():265-71. PubMed ID: 305375
[TBL] [Abstract][Full Text] [Related]
35. Effects of C. parvum on growth and induction of intracerebral tumours in mice.
Osborn DE; Sadler TE; Castro JE
Br J Cancer; 1977 Apr; 35(4):420-5. PubMed ID: 857825
[TBL] [Abstract][Full Text] [Related]
36. Tumor growth inhibition and potentiation of immunotherapy by indomethacin in mice.
Lynch NR; Salomon JC
J Natl Cancer Inst; 1979 Jan; 62(1):117-21. PubMed ID: 281566
[TBL] [Abstract][Full Text] [Related]
37. Macrophage and T lymphocyte content of tumors in mice treated with Propionibacterium.
Roszkowski K; Roszkowski W; Ko HL; Pulverer G; Jeljaszewicz J
Oncology; 1981; 38(6):334-9. PubMed ID: 6975454
[TBL] [Abstract][Full Text] [Related]
38. Proceedings: Immunotherapy of Moloney sarcoma virus tumours in mice with Corynebacterium parvum.
Hamilton DN; Bell PR
Br J Surg; 1974 Apr; 61(4):321. PubMed ID: 4832648
[No Abstract] [Full Text] [Related]
39. Immunospecific regression of methylcholanthrene fibrosarcoma with the use of neuraminidase.
Simmons RL; Rios A; Lundgren G; Ray PK; McKhann CF; Haywood GR
Surgery; 1971 Jul; 70(1):38-46. PubMed ID: 5092115
[No Abstract] [Full Text] [Related]
40. Macrophage heterogeneity in tumor resistance: cytostatic and cytotoxic activity of Corynebacterium parvum-activated and proteose peptone-elicited rat macrophages against Moloney sarcoma tumor cells.
Campbell MW; Sholley MM; Miller GA
Cell Immunol; 1980 Mar; 50(1):153-68. PubMed ID: 7397781
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
